Evidence map›Paper›PMID 31374571›Full record

ArticleThe American journal of clinical nutrition2019

Persistent low body weight in humans is associated with higher mitochondrial activity in white adipose tissue.

Yiin Ling, Jérôme Carayol, Bogdan Galusca, Carles Canto, Christophe Montaurier, Alice Matone, Irene Vassallo, Kaori Minehira, Virginie Alexandre, Ornella Cominetti and 16 more

Registry-linked trialAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02004821 (Génomique de la résistance à la Prise de Poids Dans la Maigreur Constitutionnelle), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02004821 nacompletednot on this map

Génomique de la résistance à la Prise de Poids Dans la Maigreur Constitutionnelle

TypeinterventionalSponsorSociété des Produits Nestlé (SPN)Ran2013 to 2016Enrolled60ConditionsIndividuals With Constitutional ThinnessArmsRenutryl® Booster, an oral nutritional supplement in a 300 ml bottle (600 kcal, 30 g protein, 72 g carbohydrate, 21 g fat). One bottle per day during 14 days.
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Physiological protection against weight gain: evidence from overfeeding studies and future directions.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Yiin LingDivision of Endocrinology, Diabetes, Metabolism, and Eating Disorders, CHU St-Etienne, France.
Jérôme CarayolMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Bogdan GaluscaDivision of Endocrinology, Diabetes, Metabolism, and Eating Disorders, CHU St-Etienne, France.
Carles CantoMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Christophe MontaurierClermont Auvergne University, INRA, Human Nutrition Unit, CHU Clermont-Ferrand, Service de Nutrition Clinique, CRNH Auvergne, Clermont-Ferrand, France.
Alice MatoneThe Microsoft Research, University of Trento Centre for Computational Systems Biology (COSBI), Rovereto, Italy.
Irene VassalloPrecision Medicine Group, Quartz Bio SA, Geneva, Switzerland.
Kaori MinehiraMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Virginie AlexandreMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Ornella CominettiProteomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Antonio Núñez GalindoProteomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
John CorthésyProteomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Loïc DayonProteomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Aline CharpagneGenomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Sylviane MétaironGenomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Frédéric RaymondGenomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Patrick DescombesGenomics, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
François CasteilloPathology Department, CHU St-Etienne, France.
Michel Peoc'hPathology Department, CHU St-Etienne, France.
Radu PalaghiuSurgery Department, CHU St-Etienne, France.
Léonard FéassonInteruniversity Laboratory of Motricity and Biology (LIBM) EA 7424, Jean Monnet University, St-Etienne, France.
Yves BoirieClermont Auvergne University, INRA, Human Nutrition Unit, CHU Clermont-Ferrand, Service de Nutrition Clinique, CRNH Auvergne, Clermont-Ferrand, France.
Bruno EstourDivision of Endocrinology, Diabetes, Metabolism, and Eating Disorders, CHU St-Etienne, France.
Jörg HagerMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.
Natacha GermainDivision of Endocrinology, Diabetes, Metabolism, and Eating Disorders, CHU St-Etienne, France.
Nele GheldofMetabolic Health, Nestlé Research, EPFL Innovation Park, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConstitutional thinness (CT) is a state of low but stable body weight (BMI ≤18 kg/m2). CT subjects have normal-range hormonal profiles and food intake but exhibit resistance to weight gain despite living in the modern world's obesogenic environment.

objectiveThe goal of this study is to identify molecular mechanisms underlying this protective phenotype against weight gain.

methodsWe conducted a clinical overfeeding study on 30 CT subjects and 30 controls (BMI 20-25 kg/m2) matched for age and sex. We performed clinical and integrative molecular and transcriptomic analyses on white adipose and muscle tissues.

resultsOur results demonstrate that adipocytes were markedly smaller in CT individuals (mean ± SEM: 2174 ± 142 μm 2) compared with controls (3586 ± 216 μm2) (P < 0.01). The mitochondrial respiratory capacity was higher in CT adipose tissue, particularly at the level of complex II of the electron transport chain (2.2-fold increase; P < 0.01). This higher activity was paralleled by an increase in mitochondrial number (CT compared with control: 784 ± 27 compared with 675 ± 30 mitochondrial DNA molecules per cell; P < 0.05). No evidence for uncoupled respiration or "browning" of the white adipose tissue was found. In accordance with the mitochondrial differences, CT subjects had a distinct adipose transcriptomic profile [62 differentially expressed genes (false discovery rate of 0.1 and log fold change >0.75)], with many differentially expressed genes associating with positive metabolic outcomes. Pathway analyses revealed an increase in fatty acid oxidation ( P = 3 × 10-04) but also triglyceride biosynthesis (P = 3.6 × 10-04). No differential response to the overfeeding was observed in the 2 groups.

conclusionsThe distinct molecular signature of the adipose tissue in CT individuals suggests the presence of augm ented futile lipid cycling, rather than mitochondrial uncoupling, as a way to increase energy expenditure in CT individuals. We propose that increased mitochondrial function in adipose tissue is an important mediator in sustaining the low body weight in CT individuals. This knowledge could ultimately allow more targeted approaches for weight management treatment strategies. This trial was registered at clinicaltrials.gov as NCT02004821.

Indexed as

Adipocytes, WhiteAdipose Tissue, WhiteAdultCase-Control StudiesEnergy IntakeFemaleGene Expression ProfilingHumansMaleMitochondriaThinnessTime FactorsTranscriptomeYoung Adultconstitutional thinnessfutile lipid cyclingmitochondriaproteomicsrespirationtranscriptome analysiswhite adipose tissue

Identifiers

PMID31374571
PMCPMC6736451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.